SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001517022-24-000033
Filing Date
2024-04-16
Accepted
2024-04-16 07:33:59
Documents
1
Period of Report
2024-04-15
Items
Item 1.01: Entry into a Material Definitive Agreement

Document Format Files

Seq Description Document Type Size
1 8-K akba-20241504xwuxiamendment.htm 8-K 25913
  Complete submission text file 0001517022-24-000033.txt   26992
Mailing Address 245 FIRST STREET CAMBRIDGE MA 02142
Business Address 245 FIRST STREET CAMBRIDGE MA 02142 617-871-2098
Akebia Therapeutics, Inc. (Filer) CIK: 0001517022 (see all company filings)

IRS No.: 208756903 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-36352 | Film No.: 24846109
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)